Institutional Ownership
Rein Therapeutics Inc
CUSIP 00887A204COM NEWRNTXQ1 2026
13D / 13G Filings
13
Schedule 13D/13G on record
Beneficial Filers
8
Distinct reporting persons
Largest Stake
19.9%
Max % of class reported
Institutional Holders
43
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
13 filings · latest Feb 13, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 13, 2026 | Voss Value Master Fund, LP | 13G/A | 17.0% | 4.47M | SEC |
| 2 | Sep 26, 2025 | Voss Value Master Fund, LP | 13G/A | 11.3% | 2.67M | SEC |
| 3 | Aug 11, 2025 | Bios Fund III, LP | 13G | 6.2% | 3.68M | SEC |
| 4 | May 14, 2025 | Voss Value Master Fund, LP | 13G | 5.6% | 1.28M | SEC |
| 5 | Nov 5, 2024 | University Of Texas/Texas Am Investment Management Co | 13G/A | 4.4% | 960.7K | SEC |
| 6 | Apr 16, 2024 | Satter Muneer A | 13D/A | 4.9% | 830.5K | SEC |
| 7 | Mar 5, 2024 | University Of Texas/Texas Am Investment Managment Co | 13G | 6.2% | 1.81M | SEC |
| 8 | Mar 5, 2024 | Satter Muneer A | 13D/A | 5.9% | 1.02M | SEC |
| 9 | Feb 14, 2024 | Biotechnology Value Fund L P | 13G/A | — | — | SEC |
| 10 | Feb 5, 2024 | Kapnick Scott | 13G/A | — | — | SEC |
3 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Rein Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Voss Capital, LP | 4.39M | $5.70M |
| 2 | Bios Capital Management, LP | 1.98M | $2.58M |
| 3 | University Of Texas/Texas Am Investment Management Co | 511.6K | $665.1K |
| 4 | Cable Car Capital, LP | 420.0K | $546.0K |
| 5 | Prosight Management, LP | 411.6K | $535.1K |
| 6 | Sigma Planning Corp | 348.7K | $453.3K |
| 7 | Geode Capital Management, LLC | 344.7K | $448.2K |
| 8 | Texas Capital Bank Wealth Management Services Inc | 273.6K | $355.7K |
| 9 | Gagnon Securities LLC | 239.5K | $311.4K |
| 10 | Senvest Management, LLC | 230.9K | $300.2K |